What Boiron does

Boiron is a French pharmaceutical company founded in 1932 in Lyon that manufactures and distributes homeopathic medicines, dietary supplements, cosmetics, biocides, and storage solutions for consumer health. Its portfolio is anchored by Arnica-based product lines (Arnica, Arnicare, Arnipatch) and extended through brands such as Oscillo, Stodal Plantes, Homeodent, Dapis, Dermoplasmine, Magnésium, and the more recently launched CBD by Boiron (October 2023) and ThroatCalm Spray (October 2024). Manufacturing is built around a proprietary three-step process — controlled dilution, standardized dynamization (150 shakes over 7 seconds), and triple impregnation — executed at facilities in Messimy (HQ), Montévrain, and Lyon under BPF (France) and GMP (USA) certifications with routine ANSM and FDA inspections. Approximately 2,600 employees worldwide support production, with 1,700 based in France.

The company monetizes primarily through unit-priced sales of one-time-purchase products distributed via French pharmacies (where pharmacist-dispensed pricing applies) and an e-commerce boutique selling supplements, cosmetics, and CBD wellness items. Internationally, Boiron operates 21 wholly-owned subsidiaries and roughly 20 local distributors reaching nearly 50 countries, generating approximately 60% of group revenue outside France. Revenue for 2025 was reported at EUR 501 million. Beyond consumer products, Boiron monetizes clinical credibility through institutional partnerships — including INSERM, CNRS Lyon, University of Basel, the Homeopathy Research Institute, Institut Rafaël (integrative oncology since 2019), and France's medical cannabis pilot — and uses an enterprise field-sales motion targeting physicians, pharmacists, midwives, gynecologists, and oncologists via the boiron-pro.fr portal.

Ownership and governance are family-controlled: Anabelle Flory-Boiron chairs the Board, Pascal Houdayer serves as Director General since 2024, and Thierry Boiron acts as Deputy CEO. In 2024 EW Healthcare Partners became a minority shareholder in Boiron Développement, introducing the first external institutional capital. A EUR 3.2 million investment in Panaxia Pharmaceutical Industries (Malta) in 2026, with a call option to take a majority stake by 2029, signals expansion into regulated medical cannabis alongside the existing homeopathy core.

Name

Boiron

Legal name

Les Laboratoires BOIRON

Website

https://boiron.fr

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Homeopathic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Compounding Pharmacies (Veterinary) (HLAMAIAD)

Keywords

• Homeopathic medicines
• Pharmaceutical manufacturing
• Dietary supplements
• Natural health products
• Integrative medicine

Headquarters

HQ city

Rontalon

HQ country

France

HQ region

Europe

Offices9 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Homeopathic medicines: Sale of homeopathic medications for human and veterinary use, sold primarily through pharmacy networks in France and internationally through subsidiaries
2. Dietary supplements: Sale of food supplements (compléments alimentaires) through the online boutique and pharmacies
3. Cosmetics: Sale of cosmetics including Arnipatch patches, CBD massage oils, and diaper change cream through pharmacy and e-commerce channels
4. CBD wellness products: CBD-based wellness products under the CBD by Boiron brand, launched in October 2023
5. Biocides: Mosquito repellent and other biocidal products
6. Storage solutions: Organizational and storage products for health products

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Core offering

Boiron manufactures and distributes a portfolio of homeopathic medicines (custom homeopathy, conventional medicines, veterinary homeopathy), dietary supplements, cosmetics, CBD wellness products, biocides, and storage solutions. Products are sold primarily through pharmacy networks in France and through 21 international subsidiaries plus local distributors across nearly 50 countries worldwide. Flagship lines include Arnica/Arnicare for pain and recovery, Oscillo and Stodal Plantes for respiratory wellness, Homeodent for oral care, and CBD by Boiron wellness products.

Product overview

Boiron offers a diversified portfolio of homeopathic medicines, dietary supplements, cosmetics, and wellness products distributed through pharmacies. The core offering centers on homeopathic remedies using Arnica as a flagship ingredient across multiple product lines (Arnica, Arnicare, Arnipatch). The portfolio expands into CBD-based wellness products (CBD by Boiron), oral care (Homeodent), respiratory support (Stodal Plantes, Oscillo), and topical solutions (Dapis, Dermoplasmine). Products are categorized into three main families: custom homeopathy, conventional medicines, and veterinary homeopathic medicines, complemented by dietary supplements, cosmetics, CBD wellness products, and biocides sold through pharmacies and the e-commerce boutique.

Differentiator

Problem solved

Functional benefit

Brands

• Arnica: Homeopathic pain relief brand featuring Arnica-based products for muscle pain, stiffness, and recovery
• CBD by Boiron
• Dapis
• Dermoplasmine
• Homeodent
• Oscillo
• Stodal Plantes
• Arnicare
• ThroatCalm
• Arnipatch

Products and services

• Arnica product line
• CBD by Boiron
• Oscillo' food supplement
• Arnipatch cosmetic patch
• Dapis homeopathic line
• Dermoplasmine skincare line
• Homeodent oral care line
• Magnesium supplement line
• Stodal Plantes cough remedy
• ThroatCalm Spray
• Arnicare pain relief line

Quantifiable outcome

• 200 million people worldwide use homeopathic medicines
• +4 more outcomes

Named customers3 records

Segments9 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Former MLS star Sébastien Le TouxminorGTM or Marketing Partner · 1 June 2026Arnicare by Boiron partnership with former MLS star Sébastien Le Toux to promote Arnica-based pain relief products during FIFA World Cup 2026, hosting media and influencers at MetLife Stadium during the France vs. Senegal match.
• Panaxia Pharmaceutical Industries (Malta)coreStrategic or Co-development Partner · 1 April 2026Boiron invested EUR 3.2 million in Panaxia Malta as part of strategic partnership. Boiron received a call option to acquire a majority stake by 2029. Both companies have been active in France's medical cannabis pilot program since 2019, which has enabled 3,000 patients to access regulated treatments.
• Podcast 'Allez j'ose!'minorGTM or Marketing Partner · 1 January 2024Boiron partnered with the 'Allez j'ose!' podcast hosted by Elsa Wolinski, which addresses menopause awareness without taboos, featuring women and health experts.
• Entreprise des PossiblesminorGTM or Marketing Partner · 1 January 2023Boiron joined 'Entreprise des Possibles' in 2023, a solidarity initiative among Lyon companies, becoming the 150th member company.
• Courir POUR ELLESminorGTM or Marketing Partner · 1 January 2020Long-standing partnership supporting the 'Courir POUR ELLES' solidarity race dedicated to fighting women's cancers. Boiron sponsors the Bouger POUR ELLES initiative.
• Institut RafaëlcoreStrategic or Co-development Partner · 1 January 2019Boiron is a partner of Institut Rafaël, an integrative medicine center in Levallois-Perret providing comprehensive cancer care. Boiron co-organized the first Integrative Oncology Days in 2019, bringing together practitioners from around the world.
• France medical cannabis pilot programcoreStrategic or Co-development Partner · 1 January 2019Both Boiron and Panaxia have been active in France's medical cannabis pilot program since 2019, enabling 3,000 patients to access regulated treatments.
• INSERM (Institut national de la santé et de la recherche médicale)coreTechnology or IntegrationBoiron collaborates with INSERM on fundamental and clinical research in homeopathy, particularly in areas of respiratory infections, nervous system, oncology support, and traumatology.
• CNRS de Lyon (Centre National de la Recherche Scientifique)coreTechnology or IntegrationCollaborative research partnership with CNRS Lyon for fundamental research on homeopathic mechanisms and natural substance behaviors.
• University of BaselcoreTechnology or IntegrationInternational academic research partnership for homeopathy research and scientific collaboration.
• University of Champagne-ArdennecoreTechnology or IntegrationAcademic research collaboration for fundamental and clinical studies in homeopathy.
• Homeopathy Research Institute (HRI)coreTechnology or IntegrationUK-based institute plays an essential role in supporting scientific research and disseminating findings to the public and healthcare professionals. Boiron supports HRI's mission for global homeopathy research.

Scale indicators14 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Heel Group: Heel is a German-based pharmaceutical company specializing in homeopathic and natural medicines, producing combination homeopathic preparations distributed globally. It directly competes with Boiron in the European homeopathy market with similar product formats, pharmacy distribution, and clinical positioning across musculoskeletal, respiratory, and pediatric indications.
• Deutsche Homöopathie-Union (DHU) / Schwabe Group: Schwabe Group's DHU subsidiary is one of the largest homeopathic medicine manufacturers in Germany, with a portfolio spanning single remedies, complex formulations, and Schuessler salts. It is a direct competitor to Boiron in pharmacy-channel homeopathic products, with comparable regulatory expertise and international footprint across Europe and emerging markets.
• Nelsons (Nelsonbach): Nelsons is a UK-based homeopathic manufacturer producing Rescue Remedy, Bach Flower Remedies, and homeopathic medicines. It competes directly with Boiron in UK and international consumer homeopathy markets with similar pharmacy and natural health store distribution, sharing end-user segments in stress, sleep, and general wellness.
• Hyland's: Hyland's is a US-based homeopathic medicine manufacturer with a broad OTC portfolio spanning cold/cough, sleep, pain relief, and teething products. It is Boiron's most direct US competitor in pharmacy-channel homeopathic products, particularly in the pediatric segment (teething, cold) where Boiron also targets parents seeking gentle treatments.
• Similasan: Similasan is a Swiss-headquartered homeopathic manufacturer specializing in OTC eye, ear, and nasal products distributed in the US and Europe. It is a direct peer in pharmacy-channel homeopathic OTC products, overlapping with Boiron in consumer health categories and natural remedies positioning.

Broad incumbents

• Pierre Fabre: Pierre Fabre is a major French pharmaceutical and dermo-cosmetic company with a broad portfolio spanning prescription drugs, OTC products, and natural health. While not homeopathy-focused, it competes with Boiron in French pharmacy channels across dermatology, pediatrics, and consumer health categories where both brands occupy shelf space.
• Sanofi Consumer Healthcare: Sanofi operates a broad consumer healthcare portfolio including OTC medications, dietary supplements, and pharmacy-distributed brands across cough/cold, pain, and wellness categories. It competes with Boiron in pharmacy channels globally and represents the larger-scale incumbents that can leverage broader R&D, regulatory, and distribution resources.
• Bayer Consumer Health: Bayer's Consumer Health division includes OTC brands across pain, cold/flu, dermatology, and nutrition sold through pharmacy channels worldwide. It is a broad incumbent that competes with Boiron across multiple therapeutic categories in pharmacy retail, particularly in cough/cold (Stodal/Oscillo overlap with Bayer products) and topical pain relief.

Emerging players

• Weleda: Weleda is a Swiss-based natural cosmetics and anthroposophic medicine manufacturer with a portfolio overlapping Boiron's in natural skincare, baby care, and plant-based wellness products. While not strictly homeopathic, it competes for the same natural-medicine consumer and pharmacy distribution channels across Europe.
• A.Vogel / Bioforce: A.Vogel (Bioforce) is a Swiss manufacturer of herbal and natural medicines focused on plant-based OTC products distributed through pharmacies and health stores. It is an emerging player in the natural pharmacy channel that competes with Boiron in stress, sleep, immunity, and women's health categories where consumer overlap is meaningful.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BoironFR
• LinkedInlinkedin.com/company/laboratoire-boiron

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boiron